Early Diagosis, Therapy, and Long Term Follow up of Dementia

Research output: Contribution to journalArticle

Abstract

Since the start of long term care insurance and the availability of Cholinesterase inhibitor as a prescription drug in Japan, detection and diagnosis of dementia in the early stage of the disease has become an important issue. Neuropsychological screening and imaging tools usually employed for diagnosis are insufficient. The use of diagnostic criteria to designate early stage patients is still controversial. Several disease entities, including mild cognitive impairment (MCI) and age-associated memory impairment (AAMI), are not clearly defined in Japan. To study the prognosis of early stage dementia, it is important to define the diagnostic criteria. Clear identification and diagnosis of early stage dementia is important to support patients and their family members. The early detection of dementia and cognitive decline has other important aspects. One is the implication of disease diagnosis in the community; people often hesitate to use the name dementia in the early stage, even when the patients fulfill the criteria for dementia. Another aspect is the longer term follow up of the patients after early detection. For these purposes, it will become more important to emphasize a team approach consisting of medical doctors, nurses, neuropsycologists, clinical psycologists, occupational therapists and sociateam workers.

Original languageEnglish
Pages (from-to)282-285
Number of pages4
JournalJapanese Journal of Geriatrics
Volume39
Issue number3
DOIs
Publication statusPublished - 01-01-2002

Fingerprint

Secondary Prevention
Dementia
Japan
Long-Term Care Insurance
Prescription Drugs
Cholinesterase Inhibitors
Names
Nurses

All Science Journal Classification (ASJC) codes

  • Geriatrics and Gerontology

Cite this

@article{118c5545f4fe4ea6944b3f4fb17efcfd,
title = "Early Diagosis, Therapy, and Long Term Follow up of Dementia",
abstract = "Since the start of long term care insurance and the availability of Cholinesterase inhibitor as a prescription drug in Japan, detection and diagnosis of dementia in the early stage of the disease has become an important issue. Neuropsychological screening and imaging tools usually employed for diagnosis are insufficient. The use of diagnostic criteria to designate early stage patients is still controversial. Several disease entities, including mild cognitive impairment (MCI) and age-associated memory impairment (AAMI), are not clearly defined in Japan. To study the prognosis of early stage dementia, it is important to define the diagnostic criteria. Clear identification and diagnosis of early stage dementia is important to support patients and their family members. The early detection of dementia and cognitive decline has other important aspects. One is the implication of disease diagnosis in the community; people often hesitate to use the name dementia in the early stage, even when the patients fulfill the criteria for dementia. Another aspect is the longer term follow up of the patients after early detection. For these purposes, it will become more important to emphasize a team approach consisting of medical doctors, nurses, neuropsycologists, clinical psycologists, occupational therapists and sociateam workers.",
author = "Hajime Takechi",
year = "2002",
month = "1",
day = "1",
doi = "10.3143/geriatrics.39.282",
language = "English",
volume = "39",
pages = "282--285",
journal = "Japanese Journal of Geriatrics",
issn = "0300-9173",
publisher = "Japan Geriatrics Society",
number = "3",

}

Early Diagosis, Therapy, and Long Term Follow up of Dementia. / Takechi, Hajime.

In: Japanese Journal of Geriatrics, Vol. 39, No. 3, 01.01.2002, p. 282-285.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Early Diagosis, Therapy, and Long Term Follow up of Dementia

AU - Takechi, Hajime

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Since the start of long term care insurance and the availability of Cholinesterase inhibitor as a prescription drug in Japan, detection and diagnosis of dementia in the early stage of the disease has become an important issue. Neuropsychological screening and imaging tools usually employed for diagnosis are insufficient. The use of diagnostic criteria to designate early stage patients is still controversial. Several disease entities, including mild cognitive impairment (MCI) and age-associated memory impairment (AAMI), are not clearly defined in Japan. To study the prognosis of early stage dementia, it is important to define the diagnostic criteria. Clear identification and diagnosis of early stage dementia is important to support patients and their family members. The early detection of dementia and cognitive decline has other important aspects. One is the implication of disease diagnosis in the community; people often hesitate to use the name dementia in the early stage, even when the patients fulfill the criteria for dementia. Another aspect is the longer term follow up of the patients after early detection. For these purposes, it will become more important to emphasize a team approach consisting of medical doctors, nurses, neuropsycologists, clinical psycologists, occupational therapists and sociateam workers.

AB - Since the start of long term care insurance and the availability of Cholinesterase inhibitor as a prescription drug in Japan, detection and diagnosis of dementia in the early stage of the disease has become an important issue. Neuropsychological screening and imaging tools usually employed for diagnosis are insufficient. The use of diagnostic criteria to designate early stage patients is still controversial. Several disease entities, including mild cognitive impairment (MCI) and age-associated memory impairment (AAMI), are not clearly defined in Japan. To study the prognosis of early stage dementia, it is important to define the diagnostic criteria. Clear identification and diagnosis of early stage dementia is important to support patients and their family members. The early detection of dementia and cognitive decline has other important aspects. One is the implication of disease diagnosis in the community; people often hesitate to use the name dementia in the early stage, even when the patients fulfill the criteria for dementia. Another aspect is the longer term follow up of the patients after early detection. For these purposes, it will become more important to emphasize a team approach consisting of medical doctors, nurses, neuropsycologists, clinical psycologists, occupational therapists and sociateam workers.

UR - http://www.scopus.com/inward/record.url?scp=0036560831&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036560831&partnerID=8YFLogxK

U2 - 10.3143/geriatrics.39.282

DO - 10.3143/geriatrics.39.282

M3 - Article

VL - 39

SP - 282

EP - 285

JO - Japanese Journal of Geriatrics

JF - Japanese Journal of Geriatrics

SN - 0300-9173

IS - 3

ER -